Atlas Trials

Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

Clinical trial NCT05891483 · COMPLETED

Trial details

NCT number
NCT05891483
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Rhinosinusitis With Nasal Polyps
Start date
2023-09-04
Primary completion
2026-01-21
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.